FR2688785B1 - Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications. - Google Patents
Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications.Info
- Publication number
- FR2688785B1 FR2688785B1 FR9203286A FR9203286A FR2688785B1 FR 2688785 B1 FR2688785 B1 FR 2688785B1 FR 9203286 A FR9203286 A FR 9203286A FR 9203286 A FR9203286 A FR 9203286A FR 2688785 B1 FR2688785 B1 FR 2688785B1
- Authority
- FR
- France
- Prior art keywords
- inducing
- applications
- peptide sequence
- mycobacterium tuberculosis
- sequence capable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000894006 Bacteria Species 0.000 title 1
- 241001302239 Mycobacterium tuberculosis complex Species 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Physiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9203286A FR2688785B1 (fr) | 1992-03-19 | 1992-03-19 | Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications. |
PCT/FR1993/000268 WO1993019093A1 (fr) | 1992-03-19 | 1993-03-17 | Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis et ses applications |
CA002132218A CA2132218A1 (fr) | 1992-03-19 | 1993-03-17 | Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis et ses applications |
EP93920549A EP0632816A1 (fr) | 1992-03-19 | 1993-03-17 | SEQUENCE PEPTIDIQUE APTE A INDUIRE UNE REACTION D'HYPERSENSIBILITE DE TYPE RETARDE EN PRESENCE DE BACTERIES VIVANTES DU COMPLEXE $i(MYCOBACTERIUM TUBERCULOSIS) ET SES APPLICATIONS |
US08/302,771 US5599541A (en) | 1992-03-19 | 1993-03-17 | Peptide sequence capable of inducing a delayed-type hypersensitivity reaction in the presence of living bacteria of the Mycobacterium tuberculosis complex and its applications |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9203286A FR2688785B1 (fr) | 1992-03-19 | 1992-03-19 | Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications. |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2688785A1 FR2688785A1 (fr) | 1993-09-24 |
FR2688785B1 true FR2688785B1 (fr) | 1995-07-07 |
Family
ID=9427830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9203286A Expired - Fee Related FR2688785B1 (fr) | 1992-03-19 | 1992-03-19 | Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications. |
Country Status (5)
Country | Link |
---|---|
US (1) | US5599541A (fr) |
EP (1) | EP0632816A1 (fr) |
CA (1) | CA2132218A1 (fr) |
FR (1) | FR2688785B1 (fr) |
WO (1) | WO1993019093A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2677365B1 (fr) * | 1991-06-07 | 1995-08-04 | Pasteur Institut | Proteines de mycobacterium et applications. |
ES2313719T3 (es) | 1993-11-23 | 2009-03-01 | The Regents Of The University Of California | Productos extracelulares abundantes y procedimiento de produccion y uso de los mismos. |
US6752993B1 (en) | 1993-11-23 | 2004-06-22 | The Regents Of The University Of California | Abundant extracellular product vaccines and methods for their production and use |
US5714593A (en) | 1995-02-01 | 1998-02-03 | Institut Pasteur | DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein |
US20050033022A1 (en) * | 1997-09-26 | 2005-02-10 | Smithkline Beecham Biologicals Sa | Fusion proteins comprising HIV-1 Tat and/or Nef proteins |
EP1058731A2 (fr) * | 1998-03-06 | 2000-12-13 | Statens Seruminstitut | Fabrication de polypeptides mycobacteriens par une bacterie d'acide lactique |
WO2000000218A1 (fr) * | 1998-06-26 | 2000-01-06 | Aventis Pasteur | Immunisation a ciblage mucosal |
US7431919B2 (en) * | 2003-08-20 | 2008-10-07 | Avon Products, Inc | Mascara composition |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4348280A (en) * | 1974-10-21 | 1982-09-07 | Baxter Travenol Laboratories, Inc. | Proportioning dialysis machine |
US4153556A (en) * | 1977-12-28 | 1979-05-08 | Uop Inc. | Method and apparatus for conditioning demineralized water |
US4619828A (en) * | 1982-07-06 | 1986-10-28 | Connaught Laboratories, Inc. | Polysaccharide exotoxoid conjugate vaccines |
DE3243817C2 (de) * | 1982-11-26 | 1986-01-02 | Hager & Elsässer GmbH, 7000 Stuttgart | Verfahren zur Erzeugung von keimarmem Reinwasser |
US4574049B1 (en) * | 1984-06-04 | 1999-02-02 | Ionpure Filter Us Inc | Reverse osmosis system |
US4595498A (en) * | 1984-12-27 | 1986-06-17 | Thomson Components-Mostek Corporation | Water-polishing loop |
US4626346A (en) * | 1986-02-10 | 1986-12-02 | Hall Belton E | Reverse osmosis water purification system for use in limited water supply installations |
US4876193A (en) * | 1986-02-24 | 1989-10-24 | Imreg, Inc. (Delaware Corporation) | Determination of suppressor functional reserve |
JPS6380804A (ja) * | 1986-09-24 | 1988-04-11 | Toray Ind Inc | 膜分離システムの処理方法 |
US4787980A (en) * | 1986-10-01 | 1988-11-29 | Monsanto Company | Ultra pure water system monitoring |
US4770770A (en) * | 1987-09-28 | 1988-09-13 | Everpure, Inc. | Water supply system using reverse osmosis unit for treatment of water supply |
-
1992
- 1992-03-19 FR FR9203286A patent/FR2688785B1/fr not_active Expired - Fee Related
-
1993
- 1993-03-17 EP EP93920549A patent/EP0632816A1/fr not_active Withdrawn
- 1993-03-17 WO PCT/FR1993/000268 patent/WO1993019093A1/fr not_active Application Discontinuation
- 1993-03-17 CA CA002132218A patent/CA2132218A1/fr not_active Abandoned
- 1993-03-17 US US08/302,771 patent/US5599541A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5599541A (en) | 1997-02-04 |
EP0632816A1 (fr) | 1995-01-11 |
CA2132218A1 (fr) | 1993-09-30 |
WO1993019093A1 (fr) | 1993-09-30 |
FR2688785A1 (fr) | 1993-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0636802A3 (fr) | Elément de raccordement et son application. | |
EP0586019A3 (fr) | Dispositif suiveur de cible et caméra le comprenant. | |
DE69628383D1 (de) | Polyacrylfilm und damit geformte gegenstände | |
EP0639925A3 (fr) | Détection de vecteurs de mouvement. | |
MX9201416A (es) | Peptidos y pseudopeptidos antitromboticos. | |
FR2688785B1 (fr) | Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications. | |
TR26973A (tr) | Bacillus thuringiensis cryie geni ve lepidoptera takimindan böceklere karsi zehirli protein. | |
EP0691990A4 (fr) | Copolymere amphotere derive de vinylpyridine et d'acetoxystyrene | |
HK1001404A1 (en) | Isolated, tyrosinase derived peptides and uses thereof. | |
OA09233A (en) | Permanent waving process and compositions. | |
EP0638080A4 (fr) | PYRIMIDINE 7-BISUBSTITUEE-METHYL-4-OXO-3H -, 5H --PYRROLO 3,2-d -], UTILISATION PHARMACEUTIQUE ET COMPOSITIONS CONTENANT LADITE PYRIMIDINE. | |
ZA969402B (en) | Novel oligopeptides, the preparation and use thereof. | |
EP0626425A3 (fr) | Compositions thermoplastiques compartibles à base de polyesters et de polycarbonates. | |
EP0653162A4 (fr) | Colletotrichum et son utilisation. | |
IL99205A0 (en) | Nucleotide and amino acid sequences of protein 40 of m.tuberculosis and synthetic peptides derived therefrom | |
FR2702014B1 (fr) | Joint d'assemblage d'angle en onglet. | |
EP0591518A4 (fr) | Mecanisme melangeur et soufflant amplifie et ses utilisations. | |
Warnecke | Burial societies, African religion and the Church. | |
ZA9610510B (en) | Novel peptides, the preparation and use thereof. | |
IT1275486B (it) | Sistema di sintesi per l'ottenimento di piridin propil sulfo betaina, senza rischi per l'uomo e per l'ambiente | |
Pepper | The effects of goal specificity, goal difficulty and goal source on endurance performance | |
Pelucchi | Etiquetage et normalisation des $ K^{0} $ et $\overline {K^{0}} $ dans l'expérience CPLEAR | |
Janssen | Locus heterogeneity and the molecular basis of tuberous sclerosis | |
FR2747681B1 (fr) | Complexe proteique dodecaedrique adenoviral, composition le contenant et ses applications | |
Xu | Representations of locally compact groups, amenability and compactifications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |